Stay updated on Ligelizumab in CSU Adolescents & Adults Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.

Latest updates to the Ligelizumab in CSU Adolescents & Adults Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check64 days agoChange DetectedThe study has increased its locations from 182 to 183, with several new research sites added across the United States, Europe, and Asia, while also updating the intervention type and revision version.SummaryDifference14%
- Check93 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
Stay in the know with updates to Ligelizumab in CSU Adolescents & Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in CSU Adolescents & Adults Clinical Trial page.